Karpus Investment Management’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Karpus Investment Management’s Portfolio CNLM Stock Details CNLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-131,601	Closed	-$1.33M	–	190
2016 Q1	$1.33M	Hold	131,601	–	–	0.06%	130
2015 Q4	$1.31M	Hold	131,601	–	–	0.06%	142
2015 Q3	$1.3M	Buy	+131,601	New	+$1.31M	0.06%	146
2015 Q2	–	Sell	-119,600	Closed	-$1.17M	–	216
2015 Q1	$1.17M	Buy	+119,600	New	+$1.17M	0.05%	143

Karpus Investment Management's CNLM Position: Q2 2016 in Review

Karpus Investment Management sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q2 2016, closing a stake of 131,601 shares — an estimated $1.33M sold.

Karpus Investment Management first reported a position in CNLM in Q1 2015 and held it in 4 quarters. The position peaked at $1.33M in Q1 2016. 0 funds tracked by Wall St. Rank hold CNLM as of Q2 2016.

Karpus Investment Management reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q2 2016 after selling out during the quarter.
Karpus Investment Management sold 131,601 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q2 2016, an estimated $1.33M.
Karpus Investment Management first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q1 2015 and held it in 4 quarters.
Karpus Investment Management's CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $1.33M in Q1 2016.
0 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q2 2016.

Based on Karpus Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.